 | • レポートコード：MRC2Q12-19289 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、74ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、オルベレンマチニブのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 オルベレンマチニブのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 オルベレンマチニブの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 オルベレンマチニブのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのオルベレンマチニブの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のオルベレンマチニブの売上および2028年までの予測に焦点を当てています。 オルベレンマチニブのグローバル主要企業には、Ascentage Pharma Group、Innovent Bio、Tanner Pharma Groupなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 オルベレンマチニブ市場は、タイプとアプリケーションによって区分されます。世界のオルベレンマチニブ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 10mg、40mg、その他 【アプリケーション別セグメント】 臨床、研究所 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - オルベレンマチニブ製品概要 - タイプ別市場（10mg、40mg、その他） - アプリケーション別市場（臨床、研究所） - 調査の目的 ・エグゼクティブサマリー - 世界のオルベレンマチニブ販売量予測2017-2028 - 世界のオルベレンマチニブ売上予測2017-2028 - オルベレンマチニブの地域別販売量 - オルベレンマチニブの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別オルベレンマチニブ販売量 - 主要メーカー別オルベレンマチニブ売上 - 主要メーカー別オルベレンマチニブ価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（10mg、40mg、その他） - オルベレンマチニブのタイプ別販売量 - オルベレンマチニブのタイプ別売上 - オルベレンマチニブのタイプ別価格 ・アプリケーション別市場規模（臨床、研究所） - オルベレンマチニブのアプリケーション別販売量 - オルベレンマチニブのアプリケーション別売上 - オルベレンマチニブのアプリケーション別価格 ・北米市場 - 北米のオルベレンマチニブ市場規模（タイプ別、アプリケーション別） - 主要国別のオルベレンマチニブ市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのオルベレンマチニブ市場規模（タイプ別、アプリケーション別） - 主要国別のオルベレンマチニブ市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のオルベレンマチニブ市場規模（タイプ別、アプリケーション別） - 主要国別のオルベレンマチニブ市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のオルベレンマチニブ市場規模（タイプ別、アプリケーション別） - 主要国別のオルベレンマチニブ市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのオルベレンマチニブ市場規模（タイプ別、アプリケーション別） - 主要国別のオルベレンマチニブ市場規模（トルコ、サウジアラビア） ・企業情報 Ascentage Pharma Group、Innovent Bio、Tanner Pharma Group ・産業チェーン及び販売チャネル分析 - オルベレンマチニブの産業チェーン分析 - オルベレンマチニブの原材料 - オルベレンマチニブの生産プロセス - オルベレンマチニブの販売及びマーケティング - オルベレンマチニブの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - オルベレンマチニブの産業動向 - オルベレンマチニブのマーケットドライバー - オルベレンマチニブの課題 - オルベレンマチニブの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Olverembatinib is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Olverembatinib is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Olverembatinib is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Olverembatinib include Ascentage Pharma Group, Innovent Bio and Tanner Pharma Group, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Olverembatinib manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Olverembatinib market. Further, it explains the major drivers and regional dynamics of the global Olverembatinib market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Ascentage Pharma Group
Innovent Bio
Tanner Pharma Group
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Olverembatinib Segment by Type
10mg
40mg
Others
Olverembatinib Segment by Application
Clinical
Research Institute
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Olverembatinib market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Olverembatinib, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Olverembatinib, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Olverembatinib, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Olverembatinib sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Olverembatinib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Olverembatinib sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Ascentage Pharma Group, Innovent Bio and Tanner Pharma Group, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Olverembatinib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Olverembatinib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Olverembatinib sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Olverembatinib Product Introduction
1.2 Market by Type
1.2.1 Global Olverembatinib Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 10mg
1.2.3 40mg
1.2.4 Others
1.3 Market by Application
1.3.1 Global Olverembatinib Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinical
1.3.3 Research Institute
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Olverembatinib Sales Estimates and Forecasts 2017-2028
2.2 Global Olverembatinib Revenue Estimates and Forecasts 2017-2028
2.3 Global Olverembatinib Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Olverembatinib Sales by Region
2.4.1 Global Olverembatinib Sales by Region (2017-2022)
2.4.2 Global Sales Olverembatinib by Region (2023-2028)
2.5 Global Olverembatinib Revenue by Region
2.5.1 Global Olverembatinib Revenue by Region (2017-2022)
2.5.2 Global Olverembatinib Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Olverembatinib Sales by Manufacturers
3.1.1 Global Top Olverembatinib Manufacturers by Sales (2017-2022)
3.1.2 Global Olverembatinib Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Olverembatinib in 2021
3.2 Global Olverembatinib Revenue by Manufacturers
3.2.1 Global Olverembatinib Revenue by Manufacturers (2017-2022)
3.2.2 Global Olverembatinib Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Olverembatinib Revenue in 2021
3.3 Global Olverembatinib Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Olverembatinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Olverembatinib Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Olverembatinib Sales by Type
4.1.1 Global Olverembatinib Historical Sales by Type (2017-2022)
4.1.2 Global Olverembatinib Forecasted Sales by Type (2023-2028)
4.1.3 Global Olverembatinib Sales Market Share by Type (2017-2028)
4.2 Global Olverembatinib Revenue by Type
4.2.1 Global Olverembatinib Historical Revenue by Type (2017-2022)
4.2.2 Global Olverembatinib Forecasted Revenue by Type (2023-2028)
4.2.3 Global Olverembatinib Revenue Market Share by Type (2017-2028)
4.3 Global Olverembatinib Price by Type
4.3.1 Global Olverembatinib Price by Type (2017-2022)
4.3.2 Global Olverembatinib Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Olverembatinib Sales by Application
5.1.1 Global Olverembatinib Historical Sales by Application (2017-2022)
5.1.2 Global Olverembatinib Forecasted Sales by Application (2023-2028)
5.1.3 Global Olverembatinib Sales Market Share by Application (2017-2028)
5.2 Global Olverembatinib Revenue by Application
5.2.1 Global Olverembatinib Historical Revenue by Application (2017-2022)
5.2.2 Global Olverembatinib Forecasted Revenue by Application (2023-2028)
5.2.3 Global Olverembatinib Revenue Market Share by Application (2017-2028)
5.3 Global Olverembatinib Price by Application
5.3.1 Global Olverembatinib Price by Application (2017-2022)
5.3.2 Global Olverembatinib Price Forecast by Application (2023-2028)
6 North America
6.1 North America Olverembatinib Market Size by Type
6.1.1 North America Olverembatinib Sales by Type (2017-2028)
6.1.2 North America Olverembatinib Revenue by Type (2017-2028)
6.2 North America Olverembatinib Market Size by Application
6.2.1 North America Olverembatinib Sales by Application (2017-2028)
6.2.2 North America Olverembatinib Revenue by Application (2017-2028)
6.3 North America Olverembatinib Market Size by Country
6.3.1 North America Olverembatinib Sales by Country (2017-2028)
6.3.2 North America Olverembatinib Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Olverembatinib Market Size by Type
7.1.1 Europe Olverembatinib Sales by Type (2017-2028)
7.1.2 Europe Olverembatinib Revenue by Type (2017-2028)
7.2 Europe Olverembatinib Market Size by Application
7.2.1 Europe Olverembatinib Sales by Application (2017-2028)
7.2.2 Europe Olverembatinib Revenue by Application (2017-2028)
7.3 Europe Olverembatinib Market Size by Country
7.3.1 Europe Olverembatinib Sales by Country (2017-2028)
7.3.2 Europe Olverembatinib Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Olverembatinib Market Size by Type
8.1.1 Asia Pacific Olverembatinib Sales by Type (2017-2028)
8.1.2 Asia Pacific Olverembatinib Revenue by Type (2017-2028)
8.2 Asia Pacific Olverembatinib Market Size by Application
8.2.1 Asia Pacific Olverembatinib Sales by Application (2017-2028)
8.2.2 Asia Pacific Olverembatinib Revenue by Application (2017-2028)
8.3 Asia Pacific Olverembatinib Market Size by Region
8.3.1 Asia Pacific Olverembatinib Sales by Region (2017-2028)
8.3.2 Asia Pacific Olverembatinib Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Olverembatinib Market Size by Type
9.1.1 Latin America Olverembatinib Sales by Type (2017-2028)
9.1.2 Latin America Olverembatinib Revenue by Type (2017-2028)
9.2 Latin America Olverembatinib Market Size by Application
9.2.1 Latin America Olverembatinib Sales by Application (2017-2028)
9.2.2 Latin America Olverembatinib Revenue by Application (2017-2028)
9.3 Latin America Olverembatinib Market Size by Country
9.3.1 Latin America Olverembatinib Sales by Country (2017-2028)
9.3.2 Latin America Olverembatinib Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Olverembatinib Market Size by Type
10.1.1 Middle East and Africa Olverembatinib Sales by Type (2017-2028)
10.1.2 Middle East and Africa Olverembatinib Revenue by Type (2017-2028)
10.2 Middle East and Africa Olverembatinib Market Size by Application
10.2.1 Middle East and Africa Olverembatinib Sales by Application (2017-2028)
10.2.2 Middle East and Africa Olverembatinib Revenue by Application (2017-2028)
10.3 Middle East and Africa Olverembatinib Market Size by Country
10.3.1 Middle East and Africa Olverembatinib Sales by Country (2017-2028)
10.3.2 Middle East and Africa Olverembatinib Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Ascentage Pharma Group
11.1.1 Ascentage Pharma Group Corporation Information
11.1.2 Ascentage Pharma Group Overview
11.1.3 Ascentage Pharma Group Olverembatinib Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Ascentage Pharma Group Olverembatinib Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Ascentage Pharma Group Recent Developments
11.2 Innovent Bio
11.2.1 Innovent Bio Corporation Information
11.2.2 Innovent Bio Overview
11.2.3 Innovent Bio Olverembatinib Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Innovent Bio Olverembatinib Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Innovent Bio Recent Developments
11.3 Tanner Pharma Group
11.3.1 Tanner Pharma Group Corporation Information
11.3.2 Tanner Pharma Group Overview
11.3.3 Tanner Pharma Group Olverembatinib Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Tanner Pharma Group Olverembatinib Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Tanner Pharma Group Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Olverembatinib Industry Chain Analysis
12.2 Olverembatinib Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Olverembatinib Production Mode & Process
12.4 Olverembatinib Sales and Marketing
12.4.1 Olverembatinib Sales Channels
12.4.2 Olverembatinib Distributors
12.5 Olverembatinib Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Olverembatinib Industry Trends
13.2 Olverembatinib Market Drivers
13.3 Olverembatinib Market Challenges
13.4 Olverembatinib Market Restraints
14 Key Findings in The Global Olverembatinib Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer